Author:
Dilz Jasmin,Auge Isabel,Groeneveld Kathrin,Reuter Stefanie,Mrowka Ralf
Abstract
AbstractKidneys are complex organs, and reproducing their function and physiology in a laboratory setting remains difficult. During drug development, potential compounds may exhibit unexpected nephrotoxic effects, which imposes a significant financial burden on pharmaceutical companies. As a result, there is an ongoing need for more accurate model systems. The use of renal organoids to simulate responses to nephrotoxic insults has the potential to bridge the gap between preclinical drug efficacy studies in cell cultures and animal models, and the stages of clinical trials in humans. Here we established an accessible fluorescent whole-mount approach for nuclear and membrane staining to first provide an overview of the organoid histology. Furthermore, we investigated the potential of renal organoids to model responses to drug toxicity. For this purpose, organoids were treated with the chemotherapeutic agent doxorubicin for 48 h. When cell viability was assessed biochemically, the organoids demonstrated a significant, dose-dependent decline in response to the treatment. Confocal microscopy revealed visible tubular disintegration and a loss of cellular boundaries at high drug concentrations. This observation was further reinforced by a dose-dependent decrease of the nuclear area in the analyzed images. In contrast to other approaches, in this study, we provide a straightforward experimental framework for drug toxicity assessment in renal organoids that may be used in early research stages to assist screen for potential adverse effects of compounds.
Funder
Bundesministerium für Bildung und Forschung
Freistaat Thüringen
Universitätsklinikum Jena
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Wong, C. H., Siah, K. W. & Lo, A. W. Estimation of clinical trial success rates and related parameters. Biostatistics (Oxford, England) 20, 273–286. https://doi.org/10.1093/biostatistics/kxx069 (2018).
2. Hay, M., Thomas, D. W., Craighead, J. L., Economides, C. & Rosenthal, J. Clinical development success rates for investigational drugs. Nat. Biotechnol. 32, 40–51. https://doi.org/10.1038/nbt.2786 (2014).
3. Kola, I. The state of innovation in drug development. Clin. Pharmacol. Ther. 83, 227–230. https://doi.org/10.1038/sj.clpt.6100479 (2008).
4. Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. https://www.nature.com/articles/nature12517 (2013).
5. Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet. 19, 671–687. https://doi.org/10.1038/s41576-018-0051-9 (2018).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献